To conclude briefly, the investigation explained that JMJD2C drives the progression of NSCLC through modifying histone methylation of MALAT1 to upregulate miR-503-5p-targeted SEPT2, supplying a possible chance to control NSCLC. This evidence concerns the gene KDM4C and non-small cell lung carcinoma.